Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

JMV 179

Known as: JMV-179, L-Aspartic acid, N-(N-(N-(N-(N-(N-((1,1-dimethylethoxy)carbonyl)-O-sulfo-L-tyrosyl)-L-norleucyl)glycyl)-D-tryptophyl)-L-norleucyl)-, 1-(2-phenylethyl) ester 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Cholecystokinin (CCK) in the nervous system has effects opposite to those of opioids. However, the mechanism by which CCK opposes… Expand
Is this relevant?
1999
1999
The cholecystokinin-A receptor (CCK-AR) is a G protein-coupled receptor that mediates important central and peripheral… Expand
Is this relevant?
1997
1997
A region between residues 38 and 42 of the human cholecystokinin-A (CCK-A) receptor was shown to be involved in the binding of… Expand
  • figure 1
  • figure 2
  • table I
  • figure 4
  • figure 3
Is this relevant?
1996
1996
We have investigated the potential role of gastrin in the regulation of cell growth in human astrocytic tumors. To this end we… Expand
Is this relevant?
1994
1994
The ability of CCKA antagonists to inhibit full and partial CCK agonists of the rat pancreatic acinar cell CCKA receptor has been… Expand
  • table 1
  • figure I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1994
1994
During the past few years, several antagonist ligands for cholecystokinin (CCK) receptors have been discovered, but the mechanism… Expand
Is this relevant?
1994
1994
The behavioural effects of two cholecystokinin analogues Boc-Tyr(SO3H)-Nle-Gly-Trp-Nle-Asp-Phe-NH2 (JMV 236), a potent CCK… Expand
Is this relevant?
1993
1993
The full peptide antagonist of the pancreatic cholecystokinin (CCK) receptor, JMV 179, [Boc-Tyr(SO3H)-Ahx-Gly-dTrp-Ahx-Asp… Expand
Is this relevant?